Evommune, Inc. EVMN
NYSE · United States · Health Technology
$6.92-0.29 (-4.02%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.89 | -0.66 | -33.9% | $0 | -100.0% | +8.1%$13.02→$14.08 |
| Q1 2026 | 2026-05-07 | -0.64 | -0.83 | +22.9% | — | — | -3.8%$23.83→$22.92 |
| Q4 2025 | 2026-03-05 | -1.43 | -0.84 | -70.2% | — | — | +12.3%$23.59→$26.50 |
| Q3 2025 | 2025-12-11 | -8.07 | -11.35 | +28.9% | — | — | -8.2%$19.61→$18.01 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.